Chronic acid reflux disease is also known as gastroesophageal reflux disease (GERD). If you have heartburn twice a week or more, you may have GERD. Heartburn is the most common symptom, but you may also experience:
Normally, after swallowing, a valve between the esophagus and stomach opens to allow food to pass, then it closes to prevent stomach contents from “refluxing” back into the esophagus, causing a burning sensation in the chest. For people who suffer from GERD, the valve is dysfunctional and unable to prevent acid from refluxing into the esophagus.
GERD today is typically treated with medications such as histamine receptor antagonists (H2 blockers), such as Pepcid, Tagamet and Zantac, and proton pump inhibitors (PPIs), such as Nexium, Prilosec and Protonix. Facts about these pharmaceuticals include:
For people who have severe GERD, surgical intervention may be required. Though the conventional laparoscopic procedure has long been proven a very effective long-term solution, it is still “invasive.” It includes incisions and patients must remain in the hospital for up to several days. For that reason, the number of GERD sufferers who undergo the procedure is relatively small.
EsophyX TIF (transoral incisionless fundoplication) is the latest treatment for safely and effectively treating GERD, and was developed to emulate more invasive surgical techniques, but from within and completely without incisions and visible scars.
The FDA-cleared EsophyX device is completely incisionless and is performed through the mouth, rather than through an abdominal incision.
Typically lasting no more than 30-45 minutes, the procedure is performed under general anesthesia and reconstructs the antireflux barrier to restore the competency of the gastroesophageal junction.
Most patients can go home the next day and return to work within a few days.
As a completely incisionless procedure, EsophyX TIF reconstructs the antireflux barrier to provide a solution to the anatomical root cause of GERD. The procedure is for patients who are dissatisfied with current pharmaceutical therapies or are concerned about the long-term effects of daily use of reflux medications.
TIF is performed endoscopically using the innovative EsophyX surgical device from EndoGastric Solutions. In clinical studies, 79% of patients remained off daily PPIs (proton pump inhibitors) and 70% experienced a total elimination of heartburn at two years after the EsophyX TIF procedure.